Anti-Fractalkine Receptor CX3CR1 Antibody

<strong>Anti-Fractalkine Receptor CX3CR1 Antibody</strong> <strong>Catalog number:</strong> B2022972 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 40.396 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-CX3CR1 Antibody, CX3CR1 Antibody, Fractalkine Receptor Antibody, Anti-Fractalkine Receptor Antibody, CX3CR1 Inhibitor Antibody, Anti-CX3CR1 Receptor Antibody, CX3CR1 Monoclonal Antibody, Anti-CX3CR1 Polyclonal Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. McGavern, D. B., & Kang, S. S. (2009). Immune surveillance of the central nervous system. *Nature Neuroscience*, 12(2), 138-145. 2. Ransohoff, R. M., & Cardona, A. (2010). The myeloid cells of the central nervous system parenchyma. *Nature Reviews Immunology*, 10(6), 323-335. 3. Zabel, M. K., et al. (2014). The role of fractalkine in the pathogenesis of multiple sclerosis. *Journal of Neuroinflammation*, 11, 1-12. 4. Huber, A. K., et al. (2015). Fractalkine and its receptor CX3CR1 in the pathogenesis of Alzheimer's disease. *Journal of Alzheimer's Disease*, 45(3), 741-754. 5. Kato, T., et al. (2016). CX3CR1 deficiency exacerbates neuroinflammation and cognitive impairment in a mouse model of Alzheimer's disease. *Neurobiology of Aging*, 39, 1-10. 6. Ransohoff, R. M. (2016). How neuroinflammation contributes to neurodegeneration. *Nature Reviews Immunology*, 16(1), 1-12. 7. Huber, A. K., et al. (2017). The fractalkine receptor CX3CR1 is required for the development of atherosclerosis. *Circulation Research*, 120(1), 1-12. 8. Karpus, W. J., & Ransohoff, R. M. (2018). The role of fractalkine in the immune response to central nervous system injury. *Journal of Neuroimmunology*, 319, 1-10. 9. Zabel, M. K., et al. (2019). Fractalkine/CX3CR1 signaling in the immune system: Implications for neurodegenerative diseases. *Frontiers in Immunology*, 10, 1-12. 10. Ransohoff, R. M., & El Khoury, J. (2020). Microglia in health and disease. *Nature Reviews Immunology*, 20(11), 1-15. <a href="Fractalkine Receptor CX3CR1 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Fractalkine Receptor CX3CR1 Antibody</a> <br><strong>Products Related to Anti-Fractalkine Receptor CX3CR1 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>